Evidence against tetrahydrobiopterin depletion of vascular tissue exposed to nitric oxide/superoxide or nitroglycerin

Free Radical Biology and Medicine

Volumn 48, Issue 1, 2010, Pages 145-152

  Schmidt, Kurt ^a   Rehn, Margit ^a   Stessel, Heike ^a   Wölkart, Gerald ^a   Mayer, Bernd ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Endothelial nitric oxide synthase uncoupling; Free radicals; Nitroglycerin; Peroxynitrite; Superoxide; Tetrahydrobiopterin deficiency; Vascular nitrate tolerance

Indexed keywords

DIHYDROBIOPTERIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLYCERYL TRINITRATE; LINSIDOMINE; N(G) NITROARGININE; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TETRAHYDROBIOPTERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; GUINEA PIG; MALE; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; RAT;

ANIMALS; BIOPTERIN; BLOOD VESSELS; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; GUINEA PIGS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITROGLYCERIN; OXIDATION-REDUCTION; OXIDATIVE STRESS; SUPEROXIDES;

ANIMALIA; CAVIA; RATTUS;

EID: 74149093121     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.10.038     Document Type: Article

References (57)

1. Mayer B., and Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22 (1997) 477-481
2. Gorren A.C.F., and Mayer B. Nitric-oxide synthase: a cytochrome P450 family foster child. Biochim. Biophys. Acta 1770 (2007) 432-445
3. Szabo C., Ischiropoulos H., and Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev., Drug Discovery 6 (2007) 662-680
4. Milstien S., and Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem. Biophys. Res. Commun. 263 (1999) 681-684
5. Laursen J.B., Somers M., Kurz S., McCann L., Warnholtz A., Freeman B.A., Tarpey M., Fukai T., and Harrison D.G. Endothelial regulation of vasomotion in ApoE-deficient mice-implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103 (2001) 1282-1288
6. Förstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol. Chem. 387 (2006) 1521-1533
7. Stroes E., Kastelein J., Cosentino F., Erkelens W., Wever R., Koomans H., Luscher T., and Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Invest 99 (1997) 41-46
8. Tiefenbacher C.P., Bleeke T., Vahl C., Amann K., Vogt A., and Kubler W. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 102 (2000) 2172-2179
9. Heitzer T., Brockhoff C., Mayer B., Warnholtz A., Mollnau S., Henne S., Meinertz T., and Münzel T. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers-evidence for a dysfunctional nitric oxide synthase. Circ. Res. 86 (2000) E36-E41
10. Hong H.J., Hsiao G., Cheng T.H., and Yen M.H. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 38 (2001) 1044-1048
11. Higashi Y., Sasaki S., Nakagawa K., Fukuda Y., Matsuura H., Oshima T., and Chayama K. Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am. J. Hypertens 15 (2002) 326-332
12. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., Mitch W.E., and Harrison D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest 111 (2003) 1201-1209
13. Zheng J.S., Yang X.Q., Lookingland K.J., Fink G.D., Hesslinger C., Kapatos G., Kovesdi I., and Chen A.F. Gene transfer of human guanosine 5′-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108 (2003) 1238-1245
14. Pieper G.M. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J. Cardiovasc. Pharmacol. 29 (1997) 8-15
15. Heitzer T., Krohn K., Albers S., and Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 43 (2000) 1435-1438
16. Shinozaki K., Hirayama A., Nishio Y., Yoshida Y., Ohtani T., Okamura T., Masada M., Kikkawa R., Kodama K., and Kashiwagi A. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J. Am. Coll. Cardiol. 38 (2001) 1821-1828
17. Guzik T.J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., and Channon K.M. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105 (2002) 1656-1662
18. Takeda M., Yamashita T., Shinohara M., Sasaki N., Takaya T., Nakajima K., Inoue N., Masano T., Tawa H., Satomi-Kobayashi S., Toh R., Sugiyama D., Nishimura K., Yokoyama M., Hirata K.I., and Kawashima S. Plasma tetrahydrobiopterin/dihydrobiopterin ratio-a possible marker of endothelial dysfunction. Circ. J. 73 (2009) 955-962
19. Münzel T., Daiber A., and Mülsch A. Explaining the phenomenon of nitrate tolerance. Circ. Res. 97 (2005) 618-628
20. Münzel T., Sayegh H., Freeman B.A., Tarpey M.M., and Harrison D.G. Evidence for enhanced vascular superoxide anion production in nitrate tolerance-a novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest 95 (1995) 187-194
21. Münzel T., Li H., Mollnau H., Hink U., Matheis E., Hartmann M., Oelze M., Skatchkov M., Warnholtz A., Duncker L., Meinertz T., and Förstermann U. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ. Res. 86 (2000) E7-E12
22. Gori T., Burstein J.M., Ahmed S., Miner S.E.S., AlHesayen A., Kelly S., and Parker J.D. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance-a human in vivo study. Circulation 104 (2001) 1119-1123
23. Schmidt K., Klatt P., and Mayer B. Reaction of peroxynitrite with oxyhaemoglobin: interference with photometrical determination of nitric oxide. Biochem. J. 301 (1994) 645-647
24. Klatt P., Pfeiffer S., List B.M., Lehner D., Glatter O., Werner E.R., Schmidt K., and Mayer B. Characterization of heme-deficient neuronal nitric oxide synthase reveals role for heme in subunit dimerization and binding of amino acid substrate and tetrahydrobiopterin. J. Biol. Chem. 271 (1996) 7336-7342
25. Wölkart G., Wenzl M.V., Beretta M., Stessel H., Schmidt K., and Mayer B. Vascular tolerance to nitroglycerin in ascorbate deficiency. Cardiovasc. Res. 79 (2008) 304-312
26. Schmidt K., Mayer B., and Kukovetz W.R. Effect of calcium on endothelium-derived relaxing factor formation and cGMP levels in endothelial cells. Eur. J. Pharmacol. 170 (1989) 157-166
27. Schmidt K., Werner-Felmayer G., Mayer B., and Werner E.R. Preferential inhibition of inducible nitric oxide synthase in intact cells by the 4-amino analogue of tetrahydrobiopterin. Eur. J. Biochem. 259 (1999) 25-31
28. Bradford M.M.A. rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
29. Schultz G., and Böhme E. Guanylate cyclase: GTP pyrophosphate-lyase (cyclizing), E.C.4.6.1.2. In: Bergmeyer H.U., Bergmeyer J., Gra M., and l (Eds). Methods of Enzymatic Analysis (1984), Verlag Chemie, Weinheim 379-389
30. Koppenol W.H., Moreno J.J., Pryor W.A., Ischiropoulos H., and Beckman J.S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5 (1992) 834-842
31. Lass A., Suessenbacher A., Wölkart G., Mayer B., and Brunner F. Functional and analytical evidence for scavenging of oxygen radicals by l-arginine. Mol. Pharmacol. 61 (2002) 1081-1088
32. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem. J. 281 (1992) 627-630
33. List B.M., Klösch B., Völker C., Gorren A.C.F., Sessa W.C., Werner E.R., Kukovetz W.R., Schmidt K., and Mayer B. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization. Biochem. J. 323 (1997) 159-165
34. Abou-Mohamed G., Kaesemeyer W.H., Caldwell R.B., and Caldwell R.W. Role of l-arginine in the vascular actions and development of tolerance to nitroglycerin. Br. J. Pharmacol. 130 (2000) 211-218
35. Parker J.O., Parker J.D., Caldwell R.W., Farrell B., and Kaesemeyer W.H. The effect of supplemental l-arginine on tolerance development during continuous transdermal nitroglycerin therapy. J. Am. Coll. Cardiol. 39 (2002) 1199-1203
36. Vasquez-Vivar J., Whitsett J., Martasek P., Hogg N., and Kalyanaraman B. Reaction of tetrahydrobiopterin with superoxide: EPR-kinetic analysis and characterization of the pteridine radical. Free Radic. Biol. Med. 31 (2001) 975-985
37. Schmidt K., Werner E.R., Mayer B., Wachter H., and Kukovetz W.R. Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem. J. 281 (1992) 297-300
38. Pfeiffer S., Schmidt K., and Mayer B. Dityrosine formation outcompetes tyrosine nitration at low steady-state concentrations of peroxynitrite-implications for tyrosine modification by nitric oxide/superoxide in vivo. J. Biol. Chem. 275 (2000) 6346-6352
39. Mayer B., and Beretta M. The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views, and troubles. Br. J. Pharmacol. 155 (2008) 170-184
40. MacPherson J.D., Gillespie T.D., Dunkerley H.A., Maurice D.H., and Bennett B.M. Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation. J. Pharmacol. Exp. Ther. 317 (2006) 188-195
41. Kaesemeyer W.H., Ogonowski A.A., Jin L.M., Caldwell R.B., and Caldwell R.W. Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br. J. Pharmacol. 131 (2000) 1019-1023
42. Gori T., Mak S.S., Kelly S., and Parker J.D. Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans. J. Am. Coll. Cardiol 38 (2001) 1096-1101
43. Zielonka J., Vasquez-Vivar J., and Kalyanaraman B. Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine. Nat. Protoc. 3 (2008) 8-21
44. Gorren A.C.F., Russwurm M., Kollau A., Koesling D., Schmidt K., and Mayer B. Effects of nitroglycerin/l-cysteine on soluble guanylate cyclase: evidence for an activation/inactivation equilibrium controlled by nitric oxide binding and haem oxidation. Biochem. J. 390 (2005) 625-631
45. Ikejima H., Imanishi T., Tsujioka H., Kuroi A., Muragaki Y., Mochizuki S., Goto M., Yoshida K., and Akasaka T. Effect of pioglitazone on nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor. Circ. J. 72 (2008) 998-1002
46. Channon K.M. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc. Med. 14 (2004) 323-327
47. Schulz E., Jansen T., Wenzel P., Daiber A., and Münzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid. Redox Signal. 10 (2008) 1115-1126
48. Mayahi L., Heales S., Owen D., Casas J.P., Harris J., MacAllister R.J., and Hingorani A.D. (6R)-5,6,7,8-Tetrahydro-l-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1334-1339
49. Wunderlich C., Schober K., Schmeisser A., Heerwagen C., Tausche A.K., Steinbronn N., Brandt A., Kasper M., Schwencke C., Braun-Dullaeus R.C., and Strasser R.H. The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium. J. Mol. Cell. Cardiol. 44 (2008) 938-947
50. Sawabe K., Wakasugi K.O., and Hasegawa H. Tetrahydrobiopterin uptake in supplemental administration: Elevation of tissue tetrahydrobiopterin in mice following uptake of the exogenously oxidized product 7,8-dihydrobiopterin and subsequent reduction by an anti-folate-sensitive process. J. Pharmacol. Sci. 96 (2004) 124-133
51. Sawabe K., Suetake Y., Wakasugi K.O., and Hasegawa H. Accumulated BH4 in mouse liver caused by administration of either 6R-or 6SBH4 consisted solely of the 6R-diastereomer: evidence of oxidation to BH2 and enzymic reduction. Mol. Genet. Metab. 86 Suppl. 1 (2005) S145-S147
52. Fukushima T., and Nixon J.C. Analysis of reduced forms of biopterin in biological tissues and fluids. Anal. Biochem. 102 (1980) 176-188
53. Adler C., Ghisla S., Rebrin I., Haavik J., Heizmann C.W., Blau N., Kuster T., and Curtius H. C. 7-Substituted pterins in humans with suspected pterin-4a-carbinolamine dehydratase deficiency: mechanism of formation via non-enzymatic transformation from 6-substituted pterins. Eur. J. Biochem. 208 (1992) 139-144
54. Werner E.R., Gorren A.C.F., Heller R., Werner-Felmayer G., and Mayer B. Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects. Exp. Biol. Med. 228 (2003) 1291-1302
55. Mori H., Aral T., Mori K., Suzuki T., and Makino K. Does the reduced form of neopterin serve as an antioxidant?. Biochem. Mol. Biol. Int. 40 (1996) 799-806
56. Oettl K., Dikalov S., Freisleben H.J., Mlekusch W., and Reibnegger G. Spin trapping study of antioxidant properties of neopterin and 7,8-dihydroneopterin. Biochem. Biophys. Res. Commun. 234 (1997) 774-778
57. Katusic Z.S., d'Uscio L.V., and Nath K.A. Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol. Sci. 30 (2009) 48-54